Misplaced Pages

Intravitreal implants

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Anatomical diagram of a human eye

Intravitreal implants are micro device-like inserts injected into the posterior segment of the eye to treat retinal diseases releasing therapeutic drugs at a set rate over a desired period of time. The posterior segment of the eye consists of the sclera, choroid, fovea, vitreous humor, optic nerve, and retina.

Applications

Non-biodegradable implants

Inserts made with non-biodegradable materials such as polymers require a surgical removal of the implant after the end of the treatment period. Examples of these materials consist of polymers such as ethylene-vinyl acetate (EVA), polyvinyl alcohol (PVA), polyurethane (PU) and poly siloxane (PS). An advantage to these non-biodegradable implants is that they do not cause any immune response towards the retina and the release of the drug substance can be controlled by "layering polymers of different permeability."

Biodegradable implants

Biodegradable implants are made of materials, typically, either water-soluble or metabolizable to degrade into un-harmful byproducts which can be safely excreted by the human body. It is important to note the release of the therapeutic drug is determined by the degradation of the implant and the diffusion rate of the drug substance. Indicating that the higher the molecular weight of the polymer and drug substance used, the slower the release of the drug into the vitreous humor.

References

  1. Tawfik M, Chen F, Goldberg JL, Sabel BA (December 2022). "Nanomedicine and drug delivery to the retina: current status and implications for gene therapy". Naunyn-Schmiedeberg's Archives of Pharmacology. 395 (12): 1477–1507. doi:10.1007/s00210-022-02287-3. PMC 9630211. PMID 36107200.
  2. ^ Orlova ER, Gorobets AV, Dorofeev DA, Kirilik EV, Kozlova IV (2022-06-25). "Intravitreal Systems For Targeted Drug Delivery To The Posterior Eye Segment: A Systematic Review". Russian Open Medical Journal. 11 (2): e0213. doi:10.15275/rusomj.2022.0213. S2CID 252724853.
  3. Bajpai A, Bajpai J, Saini RK, Agrawal P, Tiwari A (2016-12-19). Smart Biomaterial Devices (0 ed.). CRC Press. doi:10.1201/9781315371559. ISBN 978-1-4987-0701-5.
  4. ^ García-Estrada P, García-Bon MA, López-Naranjo EJ, Basaldúa-Pérez DN, Santos A, Navarro-Partida J (May 2021). "Polymeric Implants for the Treatment of Intraocular Eye Diseases: Trends in Biodegradable and Non-Biodegradable Materials". Pharmaceutics. 13 (5): 701. doi:10.3390/pharmaceutics13050701. PMC 8151640. PMID 34065798.
  5. ^ Abdulla D, Ali Y, Menezo V, Taylor SR (April 2022). "The Use of Sustained Release Intravitreal Steroid Implants in Non-Infectious Uveitis Affecting the Posterior Segment of the Eye". Ophthalmology and Therapy. 11 (2): 479–487. doi:10.1007/s40123-022-00456-4. PMC 8800436. PMID 35092605.
Categories: